Cited by 65Treatment of Major DepressionTrace Elements in HealthTryptophan and brain disorders

Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant action

Nowak, Gabriel·2015·Pharmacological Reports

Abstract

Affective disorders (depression) are considered as chronic illnesses leading to substantial disability, morbidity and mortality. While the etiology and pathophysiology of these diseases are still poorly recognized, the most important problems concerning them are low treatment response, treatment resistance and/or tolerance and risk of relapse. Recently published review articles have already demonstrated the important role of zinc in the pathophysiology and treatment of affective disorders, plus discussed the potential value of zinc as a marker of these diseases. This present concise review will update the experimental and clinical data on the antidepressant activity of zinc and focus on the mechanisms of its action. The mechanisms involving NMDA and AMPA glutamate, 5-HT1A serotonin and the GPR39 zinc-sensing receptor and intracellular pathways will be discussed.

Integrity signals

Registry

Crossref · 10.1016/j.pharep.2015.01.015

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nowak, G.
Affiliations
Maj Institute of Pharmacology (PL)
Corresponding author
Nowak, Gabriel
Venue
Pharmacological Reports
Published
2015-06
Volume
67
Issue
3
Pages
659-662
ISSN
1734-1140 (ISSN-L)
OpenAlex
W2044950845
Cited by
65
References
57
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 9 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 9 · 2016: 9 · 2015: 7
FWCI
1.34
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmacological Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
zinc, depression, antidepressant mechanism, NMDA receptor, AMPA receptors, 5-HT1A receptor, intracellular signaling, treatment resistance, mood disorders
MeSH terms
Animals, Antidepressive Agents, Depression, Drug Therapy, Combination, Forecasting, Humans, Zinc

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review